ArticleCancer discovery2023
MDM2-PROTAC versus MDM2 Inhibitors: Beyond p53 Reactivation.
Sylvain Peuget et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ArticleCancer discovery2023
Sylvain Peuget et al.PubMed ↗Publisher ↗
No numbers read from the abstract.